Calcipotriene, Betamethasone Dipropionate

CHEBI:CHEBI_749131

Drug Classification

Important Medical Information

⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.

  • Always consult with a healthcare professional before starting, stopping, or modifying any medication.
  • Side effects may vary and this list may not be comprehensive.
  • Drug interactions may occur with other medications.

Additional Identifiers

🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.

Additional Attributes

rxcui
388525
product_type
HUMAN PRESCRIPTION DRUG
listing_expiration_date
20251231
marketing_category
ANDA
pharm_class
Vitamin D Analog [EPC]
route
TOPICAL
dosage_form
OINTMENT
labeler_name
Padagis Israel Pharmaceuticals Ltd
manufacturer_name
Padagis Israel Pharmaceuticals Ltd
marketing_start_date
20200130
package_marketing_start_date
20231205
nui
N0000175849
pharm_class_cs
Vitamin D [CS]
active_ingredient_name
CALCIPOTRIENE
unii
143NQ3779B
active_ingredient_strength
.643 mg/g
pharm_class_epc
Vitamin D Analog [EPC]
generic_name
Calcipotriene, Betamethasone Dipropionate
brand_name
Calcipotriene and Betamethasone Dipropionate
brand_name_base
Calcipotriene and Betamethasone Dipropionate
product_ndc
72162-1428
application_number
ANDA200174
spl_id
a40da955-6004-42f8-ba7c-8cf67410c699
package_ndc
72162-1428-6
package_description
1 TUBE in 1 CARTON (72162-1428-6) / 60 g in 1 TUBE
spl_set_id
d223e857-590e-48b9-b33e-1275537a508e
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class